# ubrogepant

NDC: 0074-6501
Generic name: ubrogepant
Labeler / Manufacturer: AbbVie Inc.
Product type: DRUG FOR FURTHER PROCESSING
Marketing category: DRUG FOR FURTHER PROCESSING
Dosage form: TABLET
Routes: —
Marketing started: 20260909



## Active ingredients

- UBROGEPANT: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-6501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-6501